Roche acquired Ventana Medical Systems for $89.50 per share in cash (approximately $3.4 billion), after an initial hostile bid of $75 per share was rejected. Ventana was a leader in automated tissue-based diagnostics for cancer and infectious disease, and became Roche Tissue Diagnostics.